Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition.
Saved in:
| Title: | Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition. |
|---|---|
| Authors: | Sanchez-Russo L; Glomerular Disease Institute, Central Florida Kidney Specialists, Orlando, Florida., Vasquez-Rios G; Glomerular and Genetic Diseases Center, Renal Medicine Associates, Albuquerque, New Mexico., Campbell KN; Division of Renal-Electrolyte and Hypertension, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: Kirk.Campbell@pennmedicine.upenn.edu. |
| Source: | American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2026 Jul; Vol. 88 (1), pp. 166-169. Date of Electronic Publication: 2026 May 16. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6838 (Electronic) Linking ISSN: 02726386 NLM ISO Abbreviation: Am J Kidney Dis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
